Webinar
FDA: Embracing flexibility at the agency for advancing innovative therapies
In this fireside chat, “FDA: Embracing Flexibility at the Agency for Advancing Innovative Therapies,” our experts discuss the evolving landscape of regulatory frameworks at the FDA and how flexibility is crucial for the advancement of cell and gene therapies. They share insights on the importance of engaging with various stakeholders and the role of adaptive strategies in navigating the regulatory environment to bring innovative therapies to market.
Explore how embracing flexibility and fostering collaboration with regulatory bodies can enhance the development and approval processes for innovative therapies, ultimately benefiting patients in need.
Speakers:
- Louis Cicchini - Director, Scientific Affairs, Cell & Gene Therapy at Cencora
- Celia Witten - Principal at Eliquent Life Sciences
Fill out the form to watch the session
Pardot Form
Connect with our cell and gene experts
Our tailored solutions address the unique challenges of advanced therapies, from early discovery through to patient delivery, ensuring that innovative treatments reach those who need them most. Connect with our expert team today to learn how Cencora can support your product’s journey.
